References

Abrahams, B. S., and D. H. Geschwind. 2008. Advances in autism genetics: On the threshold of a new neurobiology. Nat Rev Genet 9(5):341–355.

Anglesio, M. S., S. Kommoss, M. C. Tolcher, B. Clarke, L. Galletta, H. Porter, S. Damaraju, S. Fereday, B. J. Winterhoff, S. E. Kalloger, J. Senz, W. Yang, H. Steed, G. Allo, S. Ferguson, P. Shaw, A. Teoman, J. J. Garcia, J. K. Schoolmeester, J. Bakkum-Gamez, A. V. Tinker, D. D. Bowtell, D. G. Huntsman, C. B. Gilks, and J. N. McAlpine. 2013. Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas. J Pathol 229(1):111–120.

Baker, M. 2012. Gene data to hit milestone. Nature 487(7407):282–283.

Capdeville, R., E. Buchdunger, J. Zimmermann, and A. Matter. 2002. Glivec (sti571, imatinib), a rationally developed, targeted anticancer drug. Nat Rev Drug Discov 1(7):493–502.

CDC (Centers for Disease Control and Prevention). 2011. National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Department of Health and Human Services.

Gandhi, L., and P. A. Janne. 2012. Crizotinib for ALK-rearranged non-small cell lung cancer: A new targeted therapy for a new target. Clin Cancer Res 18(14):3737–3742.

Gneezy, U., J. A. List, and G. Wu. 2006. The uncertainty effect: When a risky prospect is valued less than its worst outcome. Q J Econ 121:1283–1309.

Grimm, T., W. Kress, G. Meng, and C. R. Muller. 2012. Risk assessment and genetic counseling in families with Duchenne muscular dystrophy. Acta Myol 31(3):179–183.

Harrison, K. D., N. S. Kadaba, R. B. Kelly, and D. Crawford. 2012. Building a life sciences innovation ecosystem. Sci Transl Med 4(157):157fs137.

Holy, T. E., and Z. Guo. 2005. Ultrasonic songs of male mice. PLoS Biol 3(12):e386.

IOM (Institute of Medicine). 2012. Evolution of translational omics: Lessons learned and the path forward. Washington, DC: The National Academies Press.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 45
References Abrahams, B. S., and D. H. Geschwind. 2008. Advances in autism genetics: On the threshold of a new neurobiology. Nat Rev Genet 9(5):341–355. Anglesio, M. S., S. Kommoss, M. C. Tolcher, B. Clarke, L. Galletta, H. Porter, S. Damaraju, S. Fereday, B. J. Winterhoff, S. E. Kalloger, J. Senz, W. Yang, H. Steed, G. Allo, S. Ferguson, P. Shaw, A. Teoman, J. J. Garcia, J. K. Schoolmeester, J. Bakkum-Gamez, A. V. Tinker, D. D. Bowtell, D. G. Huntsman, C. B. Gilks, and J. N. McAlpine. 2013. Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas. J Pathol 229(1):111–120. Baker, M. 2012. Gene data to hit milestone. Nature 487(7407):282–283. Capdeville, R., E. Buchdunger, J. Zimmermann, and A. Matter. 2002. Glivec (sti571, imatinib), a rationally developed, targeted anticancer drug. Nat Rev Drug Discov 1(7):493–502. CDC (Centers for Disease Control and Prevention). 2011. National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. Gandhi, L., and P. A. Janne. 2012. Crizotinib for ALK-rearranged non-small cell lung cancer: A new targeted therapy for a new target. Clin Cancer Res 18(14):3737–3742. Gneezy, U., J. A. List, and G. Wu. 2006. The uncertainty effect: When a risky prospect is valued less than its worst outcome. Q J Econ 121:1283–1309. Grimm, T., W. Kress, G. Meng, and C. R. Muller. 2012. Risk assessment and genetic counsel- ing in families with Duchenne muscular dystrophy. Acta Myol 31(3):179–183. Harrison, K. D., N. S. Kadaba, R. B. Kelly, and D. Crawford. 2012. Building a life sciences innovation ecosystem. Sci Transl Med 4(157):157fs137. Holy, T. E., and Z. Guo. 2005. Ultrasonic songs of male mice. PLoS Biol 3(12):e386. IOM (Institute of Medicine). 2012. Evolution of translational omics: Lessons learned and the path forward. Washington, DC: The National Academies Press. 45

OCR for page 45
46 EFFICIENCY AND EFFECTIVENESS OF GENOMIC SCIENCE TRANSLATION Iossifov, I., M. Ronemus, D. Levy, Z. Wang, I. Hakker, J. Rosenbaum, B. Yamrom, Y. H. Lee, G. Narzisi, A. Leotta, J. Kendall, E. Grabowska, B. Ma, S. Marks, L. Rodgers, A. Stepansky, J. Troge, P. Andrews, M. Bekritsky, K. Pradhan, E. Ghiban, M. Kramer, ­ J. Parla, R. Demeter, L. L. Fulton, R. S. Fulton, V. J. Magrini, K. Ye, J. C. Darnell, R. B. Darnell, E. R. Mardis, R. K. Wilson, M. C. Schatz, W. R. McCombie, and M. Wigler. 2012. De novo gene disruptions in children on the autistic spectrum. Neuron 74(2):285–299. Kodama, K., M. Horikoshi, K. Toda, S. Yamada, K. Hara, J. Irie, M. Sirota, A. A. Morgan, R. Chen, H. Ohtsu, S. Maeda, T. Kadowaki, and A. J. Butte. 2012. Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes. Proc Natl Acad Sci USA 109(18):7049–7054. Li, H., K. A. Robinson, B. Anton, I. J. Saldanha, and P. W. Ladenson. 2011. Cost-­ ffectiveness e of a novel molecular test for cytologically indeterminate thyroid nodules. J Clin Endocrinol ­ Metab 96(11):E1719–E1726. Liew, W. K., and P. B. Kang. 2013. Recent developments in the treatment of Duchenne muscular ­ dystrophy and spinal muscular atrophy. Ther Adv Neurol Disord 6(3):147–160. Mankoff, S. P., C. Brander, S. Ferrone, and F. M. Marincola. 2004. Lost in translation: O ­ bstacles to translational medicine. J Transl Med 2(1):14–18. McAlpine, J. N., K. C. Wiegand, R. Vang, B. M. Ronnett, A. Adamiak, M. Kobel, S. E. K ­ alloger, K. D. Swenerton, D. G. Huntsman, C. B. Gilks, and D. M. Miller. 2009. Her2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy. BMC Cancer 9:433. NRC (National Research Council). 2011. Toward precision medicine: Building a knowledge network for biomedical research and a new taxonomy of disease. Washington, DC: The National Academies Press. O’Roak, B. J., L. Vives, S. Girirajan, E. Karakoc, N. Krumm, B. P. Coe, R. Levy, A. Ko, C. Lee, J. D. Smith, E. H. Turner, I. B. Stanaway, B. Vernot, M. Malig, C. Baker, B. Reilly, J. M. Akey, E. Borenstein, M. J. Rieder, D. A. Nickerson, R. Bernier, J. Shendure, and E. E. Eichler. 2012. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485(7397):246–250. PCAST (President’s Council of Advisors on Science and Technology). 2012. Report to the President on propelling innovation in drug discovery, development, and evaluation. Washington, DC: Executive Office of the President. Sanders, S. J., M. T. Murtha, A. R. Gupta, J. D. Murdoch, M. J. Raubeson, A. J. Willsey, A. G. Ercan-Sencicek, N. M. DiLullo, N. N. Parikshak, J. L. Stein, M. F. Walker, G. T. Ober, N. A. Teran, Y. Song, P. El-Fishawy, R. C. Murtha, M. Choi, J. D. Overton, R. D. Bjornson, N. J. Carriero, K. A. Meyer, K. Bilguvar, S. M. Mane, N. Sestan, R. P. Lifton, M. Gunel, K. Roeder, D. H. Geschwind, B. Devlin, and M. W. State. 2012. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485(7397):237–241. Waldrop, M. M. 2011. Research at Janelia: Life on the farm. Five years in, has a lofty experi- ment in interdisciplinary research paid off? Nature 479:284–286.